iXPress Genes was awarded a Phase II Department of Defense Small Business Innovation contract to develop extremophile-derived novel antibiotics to protect soldiers from biowarfare agents.
Learn more here.
Global Space Ventures invests in teams developing foundational technologies enabling better futures at scale, and critical to U.S. national security.
iXPress Genes was awarded a Phase II Department of Defense Small Business Innovation contract to develop extremophile-derived novel antibiotics to protect soldiers from biowarfare agents.
Learn more here.